ghk-cu peptide skin benefits Therapy Scottsdale & Peoria, Arizona A Dermatologist's Take on the

The compound progressed through Phase 2 trials under ConjuChem in the mid-2000s for indications including HIV-associated lipodystrophy, but did not advance to a marketed therapeutic in any major jurisdiction

Physician Formulated

N Engl J Med

the fatty-acid modification supports once-weekly dosing

Status di ricerca: Tutti i prodotti Peptology sono destinati esclusivamente all'uso in laboratorio e alla ricerca

Czechia Greater than 99.8 % purity confirmed by COA Assay content verified at 50.7 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination High-purity peptide for controlled laboratory research For research use only not for human or veterinary use For laboratory research only